Tech Company Financing Transactions
Calyxo Funding Round
Calyxo closed a $32.7 million Series C investment round on 7/6/2022. Investors included CRG, Questa Capital and private investors.
Transaction Overview
Company Name
Announced On
7/6/2022
Transaction Type
Venture Equity
Amount
$32,700,000
Round
Series C
Investors
CRG (Lead Investor) (Luke Düster)
Questa Capital (Lead Investor) (Ryan Drant)
Proceeds Purpose
Investment Round will Fund Further Product Development and Expansion of Calyxo's Team
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4473 Willow Rd. 100
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
Calyxo, Inc. was founded in February 2016 to address the profound need for improved kidney stone treatment. Kidney stone disease is a common problem that is painful and consumes vast amounts of healthcare resources each year. We are focused on delivering innovative solutions to better meet the needs of kidney stone patients and transform the care of this condition.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Catanese
Chief Financial Officer
Douglas Hughes
VP - Bus. Development
Jee Shin
VP - General Counsel
Chris Buchko
VP - Operations
Eric Steuben
VP - R & D
Ling Tong
Browse more venture capital transactions:
Prev: 7/6/2022: Swimlane venture capital transaction
Next: 7/6/2022: Adapty venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs